Department of Ophthalmology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Department of Dermatology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
J Dermatolog Treat. 2022 Mar;33(2):762-768. doi: 10.1080/09546634.2020.1774041. Epub 2020 Jun 8.
The aim of study was to evaluate the effects of oral isotretinoin on meibomian gland (MG) morphology detected with non-contact meibography and to investigate its relation with clinical dry eye tests.
Forty-five acne patients treated with isotretinoin underwent a full ophthalmological examination at baseline and in the fourth month as follows: ocular surface disease index (OSDI) questionnaire, assessments of tear film break-up time (TFBUT), corneal fluorescein staining, Schirmer test, meibum expression, and lid margin abnormalities. Non-contact meibography imaging and noninvasive tear break up time (NI-BUT) assessments were also performed. The changes in MGs were scored (meibography score) as grade 0, no change; grade 1, mild; grade 2, moderate; and grade 3, marked.
There was a statistically significant change in OSDI, corneal fluorescein staining, lid margin abnormality, and meibum expression score during the treatment compared to baseline values ( < .001, = .02, < .001, and < .001, respectively). All meibography scores showed a positive correlation with the lid margin abnormality and meibum expression score but did not correlate with the TFBUT, NI-BUT, Schirmer test, or the corneal fluorescein staining score.
The morphologic analysis using non-contact meibography is a useful method for assessing isotretinoin-related changes in MGs.
本研究旨在评估口服异维 A 酸(isotretinoin)对非接触式睑板腺成像(meibography)检测到的睑板腺(meibomian gland,MG)形态的影响,并探讨其与临床干眼测试的关系。
45 例接受异维 A 酸治疗的痤疮患者在基线和第 4 个月进行了全面的眼科检查,包括眼表疾病指数(ocular surface disease index,OSDI)问卷、泪膜破裂时间(tear film break-up time,TFBUT)评估、角膜荧光素染色、泪液分泌试验、睑板腺分泌、睑缘异常。还进行了非接触式睑板腺成像和非侵入性泪膜破裂时间(noninvasive tear break up time,NI-BUT)评估。MG 的变化被评分(睑板腺评分)为 0 级,无变化;1 级,轻度;2 级,中度;3 级,明显。
与基线值相比,治疗期间 OSDI、角膜荧光素染色、睑缘异常和睑板腺分泌评分均有统计学意义的变化( < .001, = .02, < .001,和 < .001,分别)。所有睑板腺评分均与睑缘异常和睑板腺分泌评分呈正相关,但与 TFBUT、NI-BUT、泪液分泌试验或角膜荧光素染色评分无关。
使用非接触式睑板腺成像的形态学分析是评估异维 A 酸相关 MG 变化的有用方法。